ALLO Competitors & Alternatives
Compare Allogene Therapeutics Inc with similar stocks in the same industry
Biotechnology
ALLO
Main Stock$1.25
Tradestie Score
52
Market Cap
$275.13M
Revenue Growth
-1.0%
Analyst Upside
+620.0%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$97.10
|
$492.21M | - | 65 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$9.37
|
$468.01M | - | 58 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$11.11
|
$463.20M | - | 45 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$6.19
|
$457.09M | - | 57 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$7.07
|
$454.29M | - | 56 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$12.34
|
$448.32M | - | 44 | Compare |
|
AUTL
Autolus Therapeutics plc American Depositary Share
|
$1.58
|
$444.46M | - | 54 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
More ALLO Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
223 stocks in this industry